State Street Corp Travere Therapeutics, Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 3,483,176 shares of TVTX stock, worth $80.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,483,176

Previous 3,646,715 4.48%

Holding current value

$80.1 Million

Previous $65.3 Million 21.11%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$13.49 - $21.54 $2.21 Million - $3.52 Million	-163,539 Reduced 4.48%	3,483,176 $51.6 Million
Q1 2025 May 15, 2025	SELL	$17.07 - $23.75 $2.06 Million - $2.86 Million	-120,520 Reduced 3.2%	3,646,715 $65.3 Million
Q4 2024 Feb 14, 2025	BUY	$13.65 - $19.85 $14.1 Million - $20.5 Million	1,030,539 Added 37.66%	3,767,235 $65.6 Million
Q3 2024 Nov 14, 2024	SELL	$7.89 - $15.21 $6.11 Million - $11.8 Million	-773,981 Reduced 22.05%	2,736,696 $38.3 Million
Q2 2024 Aug 14, 2024	SELL	$5.26 - $8.28 $16.3 Million - $25.7 Million	-3,098,019 Reduced 46.88%	3,510,677 $28.9 Million
Q1 2024 May 15, 2024	BUY	$7.18 - $9.82 $9.02 Million - $12.3 Million	1,256,351 Added 23.47%	6,608,696 $51 Million
Q4 2023 Feb 14, 2024	BUY	$5.44 - $9.5 $5.21 Million - $9.09 Million	957,088 Added 21.78%	5,352,345 $48.1 Million
Q3 2023 Nov 14, 2023	SELL	$7.64 - $17.25 $10.2 Million - $23.1 Million	-1,337,379 Reduced 23.33%	4,395,257 $39.3 Million
Q2 2023 Aug 14, 2023	BUY	$15.3 - $22.61 $20.9 Million - $30.9 Million	1,364,759 Added 31.25%	5,732,636 $88.1 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $2.56 Million - $3.29 Million	143,853 Added 3.41%	4,367,877 $98.2 Million
Q4 2022 Feb 14, 2023	BUY	$18.47 - $26.14 $15 Million - $21.2 Million	810,609 Added 23.75%	4,224,024 $88.8 Million
Q3 2022 Nov 15, 2022	SELL	$22.91 - $28.63 $4.44 Million - $5.55 Million	-193,750 Reduced 5.37%	3,413,415 $84.1 Million
Q2 2022 Aug 15, 2022	BUY	$20.94 - $30.01 $13.6 Million - $19.4 Million	647,804 Added 21.89%	3,607,165 $87.4 Million
Q1 2022 May 16, 2022	BUY	$23.61 - $30.6 $1.71 Million - $2.21 Million	72,284 Added 2.5%	2,959,361 $76.3 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $2.55 Million - $3.27 Million	104,754 Added 3.76%	2,887,077 $89.6 Million
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $8.72 Million - $16.8 Million	-671,536 Reduced 19.44%	2,782,323 $67.5 Million
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $14.3 Million - $26.8 Million	1,014,332 Added 41.58%	3,453,859 $50.4 Million
Q1 2021 May 17, 2021	BUY	$23.37 - $31.77 $57 Million - $77.5 Million	2,439,527 New	2,439,527 $60.9 Million

Others Institutions Holding TVTX

# of Institutions

230

Shares Held

102M

Call Options Held

1.71M

Put Options Held

401K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.48B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Travere Therapeutics, Inc. Transaction History